Lisata Therapeutics Engages in Key September Investor Events
![Lisata Therapeutics Engages in Key September Investor Events](https://investorshangout.com/images/blog/ihnews-Lisata%20Therapeutics%20Engages%20in%20Key%20September%20Investor%20Events.jpg)
Lisata Therapeutics Engages in Key September Investor Events
BASKING RIDGE, N.J. — Lisata Therapeutics, Inc. (NASDAQ: LSTA) is excited to inform investors and interested parties about its upcoming presentations at significant industry events this September. This marks a critical opportunity for the company, which focuses on developing innovative therapies for advanced solid tumors and other serious diseases.
Participation in Annual Global Investment Conference
Lisata will present at the H.C. Wainwright 26th Annual Global Investment Conference taking place from September 9 to 11, 2024. This virtual format allows a broad audience to access presentations, with Lisata’s session available on-demand starting September 9. David J. Mazzo, PhD, the President and Chief Executive Officer of Lisata, will lead the presentation, discussing the company's innovative approaches and progress in clinical therapies.
Presence at the LSX World Congress USA
Following the global investment conference, Lisata will participate in the 2024 LSX World Congress USA on September 11-12, 2024. Unlike the virtual setting of the previous conference, this event will occur in person at the Hynes Convention Center in Boston. On September 12, Dr. Mazzo will present at 11:15 a.m. Eastern Time, providing insights into Lisata’s latest advancements and future plans.
About Lisata Therapeutics
Lisata Therapeutics is at the forefront of clinical-stage pharmaceutical development. The company is dedicated to creating transformative therapies, particularly focusing on advanced solid tumors. Its primary product candidate, certepetide, is an investigational drug that has garnered significant attention. This drug is designed to enhance the targeting and penetration of solid tumors by utilizing a novel uptake pathway, which could revolutionize the approach to cancer treatment.
Innovative Partnerships and Future Milestones
Lisata has established remarkable commercial and research partnerships that leverage its proprietary CendR Platform technology. The Company is expected to achieve numerous important milestones in the coming years, which aligns with its projected capital that will fund operations into early 2026. These developments include anticipated data releases from ongoing clinical trials that promise to bring new insights to oncology.
Investor Relations Contacts
For inquiries regarding investment opportunities, please reach out to:
Lisata Therapeutics, Inc.
John Menditto
Vice President, Investor Relations and Corporate Communications
Phone: 908-842-0084
Email: jmenditto@lisata.com
Media Relations
For media-related questions, contact:
ICR Westwicke
Elizabeth Coleman
Senior Associate
Phone: 203-682-4783
Email: elizabeth.coleman@westwicke.com
Frequently Asked Questions
What is Lisata Therapeutics focused on?
Lisata Therapeutics is dedicated to the development of innovative therapies for advanced solid tumors and serious diseases.
Who will present at the H.C. Wainwright conference?
Dr. David J. Mazzo, the President and CEO of Lisata, will be the key presenter during the conference.
When is the 2024 LSX World Congress USA taking place?
The LSX World Congress USA will be held from September 11 to 12, 2024, at the Hynes Convention Center in Boston.
What is certepetide?
Certepetide is Lisata's investigational drug designed to improve the effectiveness of anti-cancer therapies by targeting solid tumors more effectively.
How can I contact Lisata Therapeutics?
You can reach out to Lisata Therapeutics through their investor relations contacts or media relations representatives listed above.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Exploring the Future of Magnetoresistive RAM Technology Growth
- HII Launches REMUS 620 UUVs, Transforming Ocean Research Today
- Novo Nordisk's Strategic Share Repurchase Program Insights
- Exciting Merger of Dental Organizations Enhances Patient Care
- Piper Sandler Expands Public Finance Team with New Leaders
- Revolutionizing Snack Time with Innovative Chip Packaging
- ISG's Innovative AI Contracting Solutions Revolutionize Compliance
- Admiral Insurance Group Appoints Ben Rosenthal as VP of Excess Casualty
- Forrester's Insights on AI Strategies for Tech Leadership in 2025
- Albemarle's Strategic Moves in the Options Market Explored
Recent Articles
- SINTX Technologies Thrives with New Patent for Biomaterials
- Twist Bioscience Unveils Innovative Carbon Footprint Findings
- Enhancing Safety for REALTORS® with FOREWARN's Services
- ForeSee Medical Achieves Extended HITRUST r2 Certification Success
- CytomX Therapeutics Makes Progress with CX-801 Cancer Treatment
- Casella Waste Systems Expands Its Reach with Latest Acquisition
- Cyrannus Earns 2024 BizTech Honors for Innovative AI Platform
- Protara Therapeutics Highlights Choline Deficiency Study Results
- Vestis Responds to Initial Inquiry on Potential Deal
- Pinal County Attorney Enhances Efficiency with NICE Justice
- Actuate Therapeutics Updates Progress in Ewing Sarcoma Trials
- MarketAxess Enhances Partnership with BlackRock for Credit Trading
- Lucinda Warren Joins Cue Biopharma as Chief Business Officer
- Skillsoft Revolutionizes Risk Management with New Training Suite
- FlexShopper and Versatile Credit: Elevating Merchant Solutions
- CI Global Asset Management Boosts Private Markets Fund Access
- PDS Biotechnology Showcases Promising VERSATILE-002 Results
- Fifth Third Wealth Advisors Surpasses $2 Billion Milestone
- Significant Milestones Achieved in PAS-004 Toxicity Studies
- Empowering Future Data Scientists Through Analytics Challenges
- Next-Gen iRhythm Zio Monitor Shows Improved Performance at HRX
- finally Secures $200M Funding to Accelerate Growth Strategy
- Protara Therapeutics Enhances Treatment Options for Pediatric LMs
- Madryn Asset Management Welcomes Dr. Rochelle Walensky
- Scienaptic AI Receives Strategic Funding from Credit Unions
- Record Surge in Auto Dealership Transactions Fuels Market Growth
- Adtran Commits to Ambitious Net-Zero Emission Goals by 2048
- Investigation Into Acadia Healthcare’s Leadership Raises Concerns
- WEX Expands Share Buyback Program by $1 Billion for Growth
- VICI Properties Inc. Unveils Comprehensive ESG Report for 2023–2024
- The Hartford and Active Minds Unite for Mental Health Initiative
- True Expands Talent Management Portfolio with Acquisition
- Pathward's Brittany Kelley Honored Among Influential Women in Payments
- PLANTERS® Unveils Special Reserve Peanuts for National Day
- Gleipnir, Inc. Revolutionizes Investment Opportunities Through Tokenization
- Fleetworthy Rebranding: A New Era in Fleet Management
- AMS Renewable Energy Strengthens Portfolio with Collective Solar Acquisition
- Proposed Class Action Settlement for Pluralsight Investors
- The Weston Unveils The Farm for an Unmatched Culinary Journey
- Virtusa Emerges as Top Performer in Insurance IT Services
- ThriveWell: A New Era in Health, Wellness, and Longevity
- Healthcare Systems Embrace AI and Managed Services for Efficiency
- Hub International Expands Insurance Services with New Acquisition
- Empact Technologies and Crux Join Forces for Tax Credit Compliance
- Taste the Excitement: Montchevre and Mike's Hot Honey Unite
- Chulo Magazine Awards Set to Celebrate Entertainment Excellence
- Midea's Innovative Solutions at IFA 2024 Transform Heating
- Compass Care Tackles Chronic Absenteeism with New Program
- Investors Can Take Action in Spire Global, Inc. Lawsuit
- Axiad Expands Operations with New Headquarters in Silicon Valley